Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-05-26
2008-12-02
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S330000, C544S331000
Reexamination Certificate
active
07459460
ABSTRACT:
Trisubstituted heteroaromatic compounds having the structureare provided, whereinX is C or N;A and B are each independently CH or N, with the proviso that A and B cannot both be CH;R1is Ar-L-;R2is hydrogen or alkyl;or R1and R2can be joined together to form a 4- to 7-membered cycloheteroalkyl ring;R3to R8, Ar and L are as defined herein. A method for using these compounds to treat diseases associated with abnormal bone or mineral homeostasis is also provided.
REFERENCES:
patent: 4411890 (1983-10-01), Momany
patent: 6432963 (2002-08-01), Hisamichi et al.
patent: 360701 (1990-03-01), None
patent: WO 89/07110 (1989-08-01), None
patent: WO 89/07111 (1989-08-01), None
patent: WO 93/04081 (1993-03-01), None
patent: WO 00/43279 (2000-12-01), None
patent: WO 02/066036 (2002-08-01), None
Pepin et al., CAPLUS Abstract 113:78409, 1990.
Beers et al., Gastrointestinal Disorders, The Merck Manual of Diagnosis and Therapy, Seventeenth Edition (online), Section 3, Chapter 31, 1999.
Bremner et al., Therapy of Crohn's Disease in childhood, Expert Opin. Pharmacother. 3(7), pp 809-825, 2002.
Singh et al., Immune Therapy in inflammatory bowel disease and models of colitis, British Journal of Surgery, 88, pp. 1558-1569, 2001.
Robinson, Medical Therapy of Inflammatory Bowel Disease for the 21st Century, Eur. J. Surg. 164, Suppl. 582, pp. 90-98, 1998.
Hebert et al., Functions and roles of the extracellular Ca2+ -sensing receptor in the gastrointestinal tract, Cell Calcium 35, pp. 239-247, 2004.
Putney, Jr. et al., Mechanisms of capacitative calcium entry, Journal of Cell Sciences 114(12), pp. 2223-2229, 2001.
Bundgaard, Design of Prodrugs: Introduction, p. 1, 1985.
Silverman, Prodrugs and Drug Delivery Systems, The Organic Chemistry of Drug Design and Drug Action, pp. 352-400, 1992.
Arndt, D., “Mangan-Verbindungen als Oxidationsmittel in der organischen Chemie”, Methoden der Organischen Chemie (Houben-Weyl), Fourth Edition, vol. 4, Part 1b, Georg Thieme Verlag, Stuttgart, publ., Müller, Ed., ed., pp. 466-672 (1975).
Betts, M.J. et al., “ ‘Hidden’ axial chirality as a stereodirecting element in reactions involving enol(ate) intermediates. Part 2. Cyclisation reactions of methyl (4R)-3-(2-diazo-3-oxobutanyol)-1,1-dioxo-1λ6,3-(and 1-oxo-1λ4,3-) thiazolidine-4-carboxylates”, J. Chem. Soc., Perkin Trans. 1, pp. 1067-1072 (1999).
Brown, E.M. et al., “Cloning and characterization of an extracellular Ca(2+) -Sensing receptor from bovine parathyroid” Nature, vol. 366. Dec. 9, 1993. pp. 575-580.
Bundgaard, H., Chapter 5: “Design and Application of Prodrugs”, A Textbook of Drug Design and Development, Harwood Academic Publishers, publ., Krogsgaard-Larsen, P. et al., eds., pp. 113-191 (1991).
Bundgaard, H., ed., Design of Prodrugs, Elsevier Science Publishers B.V., publ. (1985) (table of contents).
Cagniant, P. et al., “No. 50. Sur la synthèse de quelques amines arylaliphatiques dérivées du β-méthyl-naphtalène”, Bull. Soc. Chim. Fr., pp. 349-353 (1943).
Clay, R.J. et al., “A Safe, Economical Method for the Preparation of β-Oxo Esters1”, Synthesis 1993, pp. 290-292.
Davis, F.A. et al., Tetrahedron Letters No. 52, 1978, pp. 51771-51774.
Edwards, J.P. et al., “Nonsteroidal Androgen Receptor Agonists Based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one”, Bioorganic & Medicinal Chemistry Letters, vol. 9, pp. 1003-1008 (1999).
Gowen, M. et al., “Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats”, The Journal of Clinical Investigation, vol. 105, No. 11, pp. 1595-1604 (2000).
Greene, T.W. et al., Protecting Groups in Organic Synthesis, Third Edition, John Wiley & Sons, Inc., publ. (1999) (table of contents).
Hamann, L.G. et al., “Discovery of a Potent, Orally Active, Nonsteroidal Androgen Receptor Agonist: 4-Ethyl-1,2,3,4-tetrahydro-6-(trifluoromethyl)-8-pyridono[5,6-g]-quinoline (LG121071)”, J. Med. Chem., vol. 42, pp. 210-212 (1999).
Lee, D.G., Chapter 11: “Phase Transfer Assisted Permanganate Oxidations”, Oxidation in Organic Chemistry, Part D, Academic Press, publ., Trahanovsky, W.S., ed., pp. 147-204 (1982).
Neer, R.M. et al., “Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis”, The New England Journal of Medicine, vol. 344, No. 19, pp. 1434-1441 (2001).
Nemeth, E.F. et al., “The role of extracellular calcium in the regulation fo intracellular calcium and cell function”. Cell Calcium (1990) vol. 11, pp. 319-321.
Norris, R.K. et al., “Kinetics and Stereochemistry of Elimination of Nitrous Acid from 1-p-Nitrophenyl-2-nitroethyl Derivatives”, Aust. J. Chem., vol. 39, pp. 281-294 (1986).
Stewart, R., Chapter 1: “Oxidation by Permanganate”, Oxidation in Organic Chemistry, Part A, Academic Press, publ., Wiberg, K.B., ed., pp. 1-68 (1965).
Wermuth, C.G. et al., Chapter 31: “Designing Prodrugs and Bioprecursors I: Carrier Prodrugs”, The Practice of Medicinal Chemistry, Academic Press, publ., Wermuth, C.G., ed., pp. 671-696 (1996).
Whitfield, J.F. et al., “Parathyroid Hormone, Its Fragments and Their Analogs for the Treatment of Osteoporosis”, Treat. Endocrinol., vol. 1, No. 3, pp. 175-190 (2002).
Cooper Christopher B.
Dickson John K.
Dodd Dharmpal S.
Ruan Zheming
Schnur Dora M.
Bristol--Myers Squibb Company
Gibbons Maureen S.
Rao Deepak
Rodney Burton
LandOfFree
Trisubstituted heteroaromatic compounds as calcium sensing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted heteroaromatic compounds as calcium sensing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted heteroaromatic compounds as calcium sensing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4046706